Join Medical Chronicle for a free, one-hour, CPD-accredited webinar on Disease modification therapy in MS. This webinar is sponsored by Activo.
Date: 17 October 2024
Time: 7pm
Topic: Disease modification therapy in MS
Speaker: Dr Dion Craig Opperman
Bio
Fellow of the College of Neurologists of South Africa (FC Neurol) by peer review since 2008.
Research: MMed dissertation on Myotonic Dystrophy
Clinical trials: We took part in various clinical trials including: Alnitidan, Aricept, SP511, Lamictin, Elitriptan, Zomitriptan, Topiramate (for migraine prophylaxis), Epilepsy, three Migraine trials, Devco D.
Specific fields of interest
- Multiple Sclerosis
- Parkinson’s Disease
- Dystonia (operates a Botox clinic for dystonia)
- Headache
- Epilepsy
- Peripheral Neurology (Nerve Conductions and EMG)
Publications
Co-author: Giampaolo, D, Bhigjee, A, Retief, C, Isaacs, M, Britz, M, Opperman, D, Govender, R, and van Rensburg, M (2013). Guideline for the diagnosis and management of multiple sclerosis: A Southern African perspective. South African Medical Journal, 103(9), 670-691.
